busulfan has been researched along with MS (Multiple Sclerosis) in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "BUF rats suffering from severe relapsing experimental autoimmune encephalomyelitis (R-EAE), a model for multiple sclerosis, were treated with intensive cytoreductive therapy and grafting of allogeneic bone marrow (BM)." | 1.29 | Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation. ( Mulder, AH; van Bekkum, DW; van Gelder, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, HL | 1 |
| Bowman, M | 1 |
| Allan, D | 1 |
| Anstee, G | 1 |
| Arnold, DL | 1 |
| Bar-Or, A | 1 |
| Bence-Bruckler, I | 1 |
| Birch, P | 1 |
| Bredeson, C | 1 |
| Chen, J | 1 |
| Fergusson, D | 1 |
| Halpenny, M | 1 |
| Hamelin, L | 1 |
| Huebsch, L | 1 |
| Hutton, B | 1 |
| Laneuville, P | 1 |
| Lapierre, Y | 1 |
| Lee, H | 1 |
| Martin, L | 1 |
| McDiarmid, S | 1 |
| O'Connor, P | 1 |
| Ramsay, T | 1 |
| Sabloff, M | 1 |
| Walker, L | 1 |
| Freedman, MS | 1 |
| Atkins, H | 1 |
| Freedman, M | 1 |
| van Gelder, M | 1 |
| Mulder, AH | 1 |
| van Bekkum, DW | 1 |
| Openshaw, H | 1 |
| Lund, BT | 1 |
| Kashyap, A | 1 |
| Atkinson, R | 1 |
| Sniecinski, I | 1 |
| Weiner, LP | 1 |
| Forman, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Targeting Multiple Sclerosis as an Autoimmune Disease With Intensive Immunoablative Therapy and Immunological Reconstitution: A Potential Curative Therapy for Patients With a Predicted Poor Prognosis[NCT01099930] | Phase 2 | 24 participants (Actual) | Interventional | 2001-08-31 | Completed | ||
| Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden - a Register-based Retrospective Observational Study[NCT05029206] | 174 participants (Actual) | Observational | 2021-05-05 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for busulfan and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Disease Progression; Female; He | 2016 |
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Disease Progression; Female; He | 2016 |
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Disease Progression; Female; He | 2016 |
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Disease Progression; Female; He | 2016 |
3 other studies available for busulfan and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis.
Topics: Animals; Antineoplastic Agents; Busulfan; Cyclophosphamide; Diagnosis, Differential; Disease Progres | 2009 |
Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Disease Mo | 1996 |
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring.
Topics: Adult; Autoantibodies; Autoantigens; Autoimmune Diseases; Brain; Busulfan; Cells, Cultured; Combined | 2000 |